Effect of Mirikizumab on Clinical and Endoscopic Outcomes Based on Prior Advanced Therapy Failure in Patients With Moderately to Severely Active Ulcerative Colitis.
Saved in:
| Title: | Effect of Mirikizumab on Clinical and Endoscopic Outcomes Based on Prior Advanced Therapy Failure in Patients With Moderately to Severely Active Ulcerative Colitis. |
|---|---|
| Authors: | Hart A; St Mark's Hospital & Imperial College London, London, UK., Navabi S; United Medical Doctors, Long Beach, California, USA., D'Haens G; Department of Gastroenterology, Amsterdam University Medical Centers, Amsterdam, the Netherlands., Matsuoka K; Toho University Sakura Medical Center, Sakura, Japan., Martín-Arranz MD; Department of Gastroenterology of La Paz University Hospital, School of Medicine, Universidad Autónoma de Madrid, Hospital La Paz Institute for Health Research, La Paz Hospital, Madrid, Spain., Atreya R; First Department of Medicine, University Hospital Erlangen, University of Erlangen-Nürnberg, Erlangen, Germany., Samaan KH; Eli Lilly and Company, Indianapolis, Indiana, USA., Dhesi E; Eli Lilly and Company, Basingstoke, UK., Redondo I; Eli Lilly and Company, Indianapolis, Indiana, USA., Zhu B; Eli Lilly and Company, Indianapolis, Indiana, USA., Paulissen J; Syneos Health, Morrisville, North Carolina, USA., Zaremba-Pechmann L; HaaPACS GmbH, Schriesheim, Germany., Baygani S; Eli Lilly and Company, Indianapolis, Indiana, USA., Limdi J; Department of Gastroenterology, Northern Care Alliance NHS Trust, Manchester, UK., Laharie D; Centre Hospitalier Universitaire de Bordeaux, Hôpital Haut-Lévêque, Service d'Hépato-gastroentérologie et Oncologie Digestive, Université de Bordeaux, Bordeaux, France., Danese S; Gastroenterology and Gastrointestinal Endoscopy Unit, IRCCS San Raffaele Scientific Institute, Vita-Salute San Raffaele University, Milano, Italy. |
| Source: | United European gastroenterology journal [United European Gastroenterol J] 2026 May; Vol. 14 (4), pp. e70214. |
| Publication Type: | Journal Article; Randomized Controlled Trial; Clinical Trial, Phase III; Multicenter Study |
| Journal Info: | Publisher: Wiley Country of Publication: England NLM ID: 101606807 Publication Model: Print Cited Medium: Internet ISSN: 2050-6414 (Electronic) Linking ISSN: 20506406 NLM ISO Abbreviation: United European Gastroenterol J Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 42104877 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Effect of Mirikizumab on Clinical and Endoscopic Outcomes Based on Prior Advanced Therapy Failure in Patients With Moderately to Severely Active Ulcerative Colitis. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Hart+A%22">Hart A</searchLink>; St Mark's Hospital & Imperial College London, London, UK.<br /><searchLink fieldCode="AU" term="%22Navabi+S%22">Navabi S</searchLink>; United Medical Doctors, Long Beach, California, USA.<br /><searchLink fieldCode="AU" term="%22D'Haens+G%22">D'Haens G</searchLink>; Department of Gastroenterology, Amsterdam University Medical Centers, Amsterdam, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Matsuoka+K%22">Matsuoka K</searchLink>; Toho University Sakura Medical Center, Sakura, Japan.<br /><searchLink fieldCode="AU" term="%22Martín-Arranz+MD%22">Martín-Arranz MD</searchLink>; Department of Gastroenterology of La Paz University Hospital, School of Medicine, Universidad Autónoma de Madrid, Hospital La Paz Institute for Health Research, La Paz Hospital, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Atreya+R%22">Atreya R</searchLink>; First Department of Medicine, University Hospital Erlangen, University of Erlangen-Nürnberg, Erlangen, Germany.<br /><searchLink fieldCode="AU" term="%22Samaan+KH%22">Samaan KH</searchLink>; Eli Lilly and Company, Indianapolis, Indiana, USA.<br /><searchLink fieldCode="AU" term="%22Dhesi+E%22">Dhesi E</searchLink>; Eli Lilly and Company, Basingstoke, UK.<br /><searchLink fieldCode="AU" term="%22Redondo+I%22">Redondo I</searchLink>; Eli Lilly and Company, Indianapolis, Indiana, USA.<br /><searchLink fieldCode="AU" term="%22Zhu+B%22">Zhu B</searchLink>; Eli Lilly and Company, Indianapolis, Indiana, USA.<br /><searchLink fieldCode="AU" term="%22Paulissen+J%22">Paulissen J</searchLink>; Syneos Health, Morrisville, North Carolina, USA.<br /><searchLink fieldCode="AU" term="%22Zaremba-Pechmann+L%22">Zaremba-Pechmann L</searchLink>; HaaPACS GmbH, Schriesheim, Germany.<br /><searchLink fieldCode="AU" term="%22Baygani+S%22">Baygani S</searchLink>; Eli Lilly and Company, Indianapolis, Indiana, USA.<br /><searchLink fieldCode="AU" term="%22Limdi+J%22">Limdi J</searchLink>; Department of Gastroenterology, Northern Care Alliance NHS Trust, Manchester, UK.<br /><searchLink fieldCode="AU" term="%22Laharie+D%22">Laharie D</searchLink>; Centre Hospitalier Universitaire de Bordeaux, Hôpital Haut-Lévêque, Service d'Hépato-gastroentérologie et Oncologie Digestive, Université de Bordeaux, Bordeaux, France.<br /><searchLink fieldCode="AU" term="%22Danese+S%22">Danese S</searchLink>; Gastroenterology and Gastrointestinal Endoscopy Unit, IRCCS San Raffaele Scientific Institute, Vita-Salute San Raffaele University, Milano, Italy. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101606807%22">United European gastroenterology journal</searchLink> [United European Gastroenterol J] 2026 May; Vol. 14 (4), pp. e70214. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Randomized Controlled Trial; Clinical Trial, Phase III; Multicenter Study – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley%22">Wiley </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101606807 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>2050-6414 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220506406%22">20506406 </searchLink><i>NLM ISO Abbreviation: </i>United European Gastroenterol J <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42104877 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1002/ueg2.70214 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: e70214 Titles: – TitleFull: Effect of Mirikizumab on Clinical and Endoscopic Outcomes Based on Prior Advanced Therapy Failure in Patients With Moderately to Severely Active Ulcerative Colitis. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Hart A – PersonEntity: Name: NameFull: Navabi S – PersonEntity: Name: NameFull: D'Haens G – PersonEntity: Name: NameFull: Matsuoka K – PersonEntity: Name: NameFull: Martín-Arranz MD – PersonEntity: Name: NameFull: Atreya R – PersonEntity: Name: NameFull: Samaan KH – PersonEntity: Name: NameFull: Dhesi E – PersonEntity: Name: NameFull: Redondo I – PersonEntity: Name: NameFull: Zhu B – PersonEntity: Name: NameFull: Paulissen J – PersonEntity: Name: NameFull: Zaremba-Pechmann L – PersonEntity: Name: NameFull: Baygani S – PersonEntity: Name: NameFull: Limdi J – PersonEntity: Name: NameFull: Laharie D – PersonEntity: Name: NameFull: Danese S IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 05 Text: 2026 May Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 2050-6414 Numbering: – Type: volume Value: 14 – Type: issue Value: 4 Titles: – TitleFull: United European gastroenterology journal Type: main |
| ResultId | 1 |